Full Text - Science Magazine (subscription)
February 15, 2007| Full Text Science Magazine (subscription) - For millions of patients that suffer from rheumatoid arthritis, simple tasks of daily life such as tying shoes and climbing steps are painful and perhaps ... |
ZymoGenetics Reports Fourth Quarter and Year End 2006 Financial ... - PR Newswire (press release)
February 15, 2007| ZymoGenetics Reports Fourth Quarter and Year End 2006 Financial ... PR Newswire (press release), NY - In December 2006, ZymoGenetics and its partner Merck Serono initiated a Phase 2 trial of atacicept with rheumatoid arthritis patients whose disease has ... |
Viruses get the silent treatment, any disease is a target - Harvard University Gazette
February 15, 2007 Harvard University Gazette | Viruses get the silent treatment, any disease is a target Harvard University Gazette, MA - RNAi also looks like a possible way to fight autoimmune diseases, such as type 1 diabetes, rheumatoid arthritis, and lupus. These are ailments caused by the ... |
Cancer Drug IPO Sees Strong Insider Interest - InvestorIdeas.com (press release)
February 15, 2007| Cancer Drug IPO Sees Strong Insider Interest InvestorIdeas.com (press release), WA - Inflammatory diseases like rheumatoid arthritis, Crohn's disease, multiple sclerosis and psoriasis are typically caused by an immune system gone awry. ... |
Jamal and his autism, 11 years later - 9NEWS.com
February 15, 2007| Jamal and his autism, 11 years later 9NEWS.com, CO - He is crippled from rheumatoid arthritis, but the structured daily routine and 24-hour care at the facility has made a difference and given hope to his ... |
Biogen Idec Q4 Profit Nearly Doubles; Non-GAAP EPS Misses Estimate ... - Trading Markets
February 15, 2007 Canada.com | Biogen Idec Q4 Profit Nearly Doubles; Non-GAAP EPS Misses Estimate ... Trading Markets, CA - ... helped by increased sales of its Multiple Sclerosis drug Avonex and B-cell non-Hodgkin's lymphoma and Rheumatoid Arthritis treatment Rituxan. ... Biogen Idec Reports Full Year and Fourth Quarter 2006 Results Biogen Idec 4Q Profit Doubles Biogen Idec lower as sector gauges slip |
Biogen Idec Reports Full Year and Fourth Quarter 2006 Results - Genetic Engineering News (press release)
February 15, 2007| Biogen Idec Reports Full Year and Fourth Quarter 2006 Results Genetic Engineering News (press release), NY - Second, we successfully launched two products: RITUXAN in rheumatoid arthritis and TYSABRI for multiple sclerosis in the US and Europe. ... |
The Immune Response Corporation's Interim Phase II Data Suggest ... - PR Newswire (press release)
February 15, 2007| The Immune Response Corporation's Interim Phase II Data Suggest ... PR Newswire (press release), NY - Vaccines' Ability to Strengthen Key Elements of the Immune System Holds Promise for New Approach to HIV Treatment - CARLSBAD, Calif., Feb. ... The Immune Response Corporation's Interim Phase II Data Suggest ... |